200 related articles for article (PubMed ID: 7107614)
1. Changes in high density lipoprotein content following endotoxin administration in the mouse. Formation of serum amyloid protein-rich subfractions.
Hoffman JS; Benditt EP
J Biol Chem; 1982 Sep; 257(17):10510-7. PubMed ID: 7107614
[TBL] [Abstract][Full Text] [Related]
2. Secretion of serum amyloid protein and assembly of serum amyloid protein-rich high density lipoprotein in primary mouse hepatocyte culture.
Hoffman JS; Benditt EP
J Biol Chem; 1982 Sep; 257(17):10518-22. PubMed ID: 6809750
[TBL] [Abstract][Full Text] [Related]
3. SAA-only HDL formed during the acute phase response in apoA-I+/+ and apoA-I-/- mice.
Cabana VG; Reardon CA; Wei B; Lukens JR; Getz GS
J Lipid Res; 1999 Jun; 40(6):1090-103. PubMed ID: 10357841
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoprotein has different binding capacity for different apoproteins. The amyloidogenic apoproteins are easier to displace from high-density lipoprotein.
Husebekk A; Skogen B; Husby G
Scand J Immunol; 1988 Dec; 28(6):653-8. PubMed ID: 3232030
[TBL] [Abstract][Full Text] [Related]
5. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition.
Coetzee GA; Strachan AF; van der Westhuyzen DR; Hoppe HC; Jeenah MS; de Beer FC
J Biol Chem; 1986 Jul; 261(21):9644-51. PubMed ID: 3525531
[TBL] [Abstract][Full Text] [Related]
6. apo-SAA1/apo-SAA2 isotype ratios during casein- and amyloid-enhancing-factor-induced secondary amyloidosis in A/J and C57BL/6J mice mice.
Hébert L; Gervais F
Scand J Immunol; 1990 Feb; 31(2):167-73. PubMed ID: 2309099
[TBL] [Abstract][Full Text] [Related]
7. Human high-density lipoprotein associated amyloid A protein. Structural characteristics, relation to apo A-I and A-II concentrations, and plasma clearance kinetics in the rat.
Ehnholm C; Teppo AM; Ohisalo JJ; Maury CP
Scand J Rheumatol; 1985; 14(2):201-8. PubMed ID: 3923617
[TBL] [Abstract][Full Text] [Related]
8. High-density lipoprotein as carrier for amyloid-related protein SAA in rabbit serum.
Skogen B; Børresen AL; Natvig JB; Berg K; Michaelsen TE
Scand J Immunol; 1979; 10(1):39-45. PubMed ID: 224449
[TBL] [Abstract][Full Text] [Related]
9. Impact of serum amyloid A on high density lipoprotein composition and levels.
de Beer MC; Webb NR; Wroblewski JM; Noffsinger VP; Rateri DL; Ji A; van der Westhuyzen DR; de Beer FC
J Lipid Res; 2010 Nov; 51(11):3117-25. PubMed ID: 20667817
[TBL] [Abstract][Full Text] [Related]
10. Metabolic disorders of serum lipoproteins in endotoxin-poisoned mice: the role of high density lipoprotein (HDL) and triglyceride-rich lipoproteins.
Sakaguchi S
Microbiol Immunol; 1982; 26(11):1017-34. PubMed ID: 6220193
[TBL] [Abstract][Full Text] [Related]
11. Hyperthyroidism influences the distribution and apolipoprotein A composition of the high density lipoproteins in man.
Muls E; Rosseneu M; Bury J; Stul M; Lamberigts G; De Moor P
J Clin Endocrinol Metab; 1985 Nov; 61(5):882-9. PubMed ID: 3930554
[TBL] [Abstract][Full Text] [Related]
12. Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice.
Tietge UJ; Maugeais C; Lund-Katz S; Grass D; deBeer FC; Rader DJ
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1213-8. PubMed ID: 12117740
[TBL] [Abstract][Full Text] [Related]
13. Expression of mouse acute-phase (SAA1.1) and constitutive (SAA4) serum amyloid A isotypes: influence on lipoprotein profiles.
Kindy MS; de Beer MC; Yu J; de Beer FC
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1543-50. PubMed ID: 10845870
[TBL] [Abstract][Full Text] [Related]
14. Differential plasma clearance of murine acute-phase serum amyloid A proteins SAA1 and SAA2.
Kluve-Beckerman B; Yamada T; Hardwick J; Liepnieks JJ; Benson MD
Biochem J; 1997 Mar; 322 ( Pt 2)(Pt 2):663-9. PubMed ID: 9065791
[TBL] [Abstract][Full Text] [Related]
15. Structural prerequisites for serum amyloid A fibril formation.
de Beer MC; de Beer FC; McCubbin WD; Kay CM; Kindy MS
J Biol Chem; 1993 Sep; 268(27):20606-12. PubMed ID: 8376413
[TBL] [Abstract][Full Text] [Related]
16. Amyloid formation in the rat: adenoviral expression of mouse serum amyloid A proteins.
Yu J; Guo JT; Zhu H; Kindy MS
Amyloid; 2000 Mar; 7(1):32-40. PubMed ID: 10842703
[TBL] [Abstract][Full Text] [Related]
17. Serum amyloid A3 is a high density lipoprotein-associated acute-phase protein.
Tannock LR; De Beer MC; Ji A; Shridas P; Noffsinger VP; den Hartigh L; Chait A; De Beer FC; Webb NR
J Lipid Res; 2018 Feb; 59(2):339-347. PubMed ID: 29247043
[TBL] [Abstract][Full Text] [Related]
18. Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice.
Hosoai H; Webb NR; Glick JM; Tietge UJ; Purdom MS; de Beer FC; Rader DJ
J Lipid Res; 1999 Apr; 40(4):648-53. PubMed ID: 10191288
[TBL] [Abstract][Full Text] [Related]
19. Characterization of amyloid proteins AA and SAA as apolipoproteins of high density lipoprotein (HDL). Displacement of SAA from the HDL-SAA complex by apo AI and apo AII.
Husebekk A; Skogen B; Husby G
Scand J Immunol; 1987 Apr; 25(4):375-81. PubMed ID: 3107118
[TBL] [Abstract][Full Text] [Related]
20. Effects of serum amyloid A on the structure and antioxidant ability of high-density lipoprotein.
Sato M; Ohkawa R; Yoshimoto A; Yano K; Ichimura N; Nishimori M; Okubo S; Yatomi Y; Tozuka M
Biosci Rep; 2016 Aug; 36(4):. PubMed ID: 27422844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
